Insomnia: risk factors, diagnosis and management
Introduction Insomnia affects a significant proportion of the global population, averaging between 5% and 50%, depending on the definition used1. It significantly impairs daily functioning, contributing to both mental and physical health issues2. Pharmacists are vital members of the multidisciplinary team and are well placed to support patients utilising evidence-based interventions3,4. Insomnia is defined by persistent […]
Publication Details
- Journal
- Pharmaceutical journal/The pharmaceutical journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1211/pj.2025.1.361290
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00